New Treatment for Dry Eyes
Newly Approved Drug, Xiidra, Keeps Dr. Jack Abrams the Leader in Patient Care
Since we live in the desert of Las Vegas, many patients at Abrams Eye Institute are dealing with the nagging, irritating and often painful problem of dry eyes and Dry Eye Disease (DED).
Just a few weeks ago the FDA approved a new drug Xiidra to treat Dry Eye Disease. If patients use Xiidra twice a day, they will see results almost immediately. This is a major development since previous treatment options can take months to start working.
In addition to Xiidra, standard treatments include artificial tears, punctal plugs and Restasis. Artificial tears help by keeping your eyes lubricated if used 4-6 times daily. Punctal plugs are used when artificial tears alone do not help. Dr. Abrams also prescribes Restasis, a prescription medication and the precursor to Xiidra. The downside of Restasis is that it can take three months to start working.
More than 25 million patients in the United States are affected by Dry Eye Disease. Symptoms include intermittent blurriness, redness, irritation and even excessive tearing. Dry eye disease includes a group of conditions in which the eye does not produce an adequate volume of tears or when the tears are not of the correct consistency. The chance of experiencing dry eye increases with age, affecting approximately five percent of the adult population age 30-40 and 10 to 15 percent of adults over age 65, and is more common among women. When severe and left untreated, this condition can lead to pain, ulcers or scars on the part of the eye called the cornea. Dry eye can make it more difficult to perform some activities, such as using a computer or reading for an extended period of time, and it can decrease tolerance for dry environments, such as the air inside an airplane.
If you are suffering from any of the above, Dr. Abrams can help. Call us to schedule an appointment so you can feel better, see better and enjoy a better quality of life.